Intro to Biomedical Research by Dr. Henske
Emerging Treatments -- mTOR Inhibitors and Beyond
Lung Involvement in TSC and Treatment Options
Interview with Lisa Henske
Today’s Voice of Kidney Cancer is Dr. Elizabeth (Lisa) Henske, who runs the Henske Lab at Brigham and Women’s Hospital and Harvard Medical School in Boston. One of her principal areas of research is chromophobe renal cell carcinoma (chRCC). She’s also one of the newest members of the KCCure scientific advisory board. We’re grateful to Dr. Henske for donating her time to answer a few questions about her work in chRCC.